Insider Holders & Insider Ownership - AMICUS THERAPEUTICS INC. (FOLD)

List of insiders holdings for AMICUS THERAPEUTICS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner		2024-02-14 16:38:2828,057,456
0		28,057,456Form 13G
Redmile Group LLC
Green Jeremy
10% Owner		2024-02-14 16:26:2221,957,926
0		21,957,926Form 13G
PERRY MARK W
10% Owner		2012-03-09 15:52:380
4,584,311		4,584,311Form 4
NEW ENTERPRISE ASSOCIATES 11 LP
NEA PARTNERS 11 LP
NEA 11 GP LLC
BASKETT FOREST
DRANT RYAN D
KOLLURI KRISHNA KITTU
SANDELL SCOTT D
10% Owner		2012-03-09 15:55:054,584,311
0		4,584,311Form 4
BARRIS PETER J
10% Owner		2012-03-09 15:54:270
4,584,311		4,584,311Form 4
KRAMLICH C RICHARD
10% Owner		2012-03-09 15:53:360
4,584,311		4,584,311Form 4
NEWHALL CHARLES W III
10% Owner		2012-03-09 15:52:560
4,584,311		4,584,311Form 4
CHL Medical Partners II Side Fund L.P.
10% Owner		2007-06-07 13:58:162,108,555
1,975,456		4,084,011Form 4
NEW ENTERPRISE ASSOCIATES 11 LP
NEA PARTNERS 11 LP
NEA 11 GP LLC
BARRETT M JAMES
BASKETT FOREST
DRANT RYAN D
KOLLURI KRISHNA KITTU
LINEHAN CHARLES M
SANDELL SCOTT D
TRAINOR III EUGENE A
10% Owner		2007-06-07 20:28:233,659,157
0		3,659,157Form 4
Garden State Life Sciences Venture Fund L P
10% Owner		2007-06-07 10:41:251,419,762
1,064,822		2,484,584Form 4
PROSPECT VENTURE PARTNERS II LP
PROSPECT ASSOCIATES II L P
PROSPECT MANAGEMENT CO II LLC
TANANBAUM JAMES B
SCHNELL DAVID
HIRSCH RUSSELL C
10% Owner		2013-01-28 17:13:592,240,752
0		2,240,752Form 13G
QUAKER BIO VENTURES LP
10% Owner		2012-02-14 14:33:031,429,762
0		1,429,762Form 13G
CHL Medical Partners II L.P.
10% Owner		2010-02-05 14:33:551,365,941
0		1,365,941Form 13G
Campbell Bradley L
President and CEO		2024-04-03 18:14:00946,654
0		946,654Form 4
Crowley John F
Executive Chairman		2024-03-15 19:14:06927,013
0		927,013Form 4/A
Canaan Equity Partners III LLC
CANAAN EQUITY III LP
CANAAN EQUITY III ENTREPRENEURS LLC
BALEN JOHN V
GREEN L STEPHEN
DEEPAK KAMRA
KOPCHINSKY GREGORY
RUDNICK SETH
RUSSO GUY M
YOUNG ERIC A
10% Owner		2010-02-10 16:10:48552,191
0		552,191Form 13G
Do Hung
Chief Science Officer		2021-04-08 20:05:06448,617
0		448,617Form 4
Quimi Daphne
Chief Financial Officer		2023-01-19 18:16:09398,532
0		398,532Form 4
Rosenberg Ellen
Chief Legal Officer		2024-03-15 19:10:32384,219
0		384,219Form 4/A
Castelli Jeff
Chief Development Officer		2024-03-15 19:12:03377,205
0		377,205Form 4/A
Clark David Michael
Chief People Officer		2024-03-15 19:13:16271,775
0		271,775Form 4/A
Harford Simon N.R.
Chief Financial Officer		2024-01-04 18:17:02263,438
0		263,438Form 4
Barth Jay
Chief Medical Officer		2020-10-02 16:34:33177,870
20		177,890Form 4
Dilone Enrique
SVP, Technical Operations		2015-06-23 20:09:25158,598
0		158,598Form 4
LOVE TED W
Director		2020-06-08 16:57:03149,574
0		149,574Form 4
Baird William D III
Chief Financial Officer		2018-10-17 18:28:05141,622
0		141,622Form 4
Weinhoff Gregory M
Director		2008-08-18 16:05:370
129,943		129,943Form 4
WHITMAN BURKE W
Director		2023-06-12 17:36:11116,811
0		116,811Form 4
Bleil Lynn Dorsey
Director		2023-06-12 17:39:11112,154
0		112,154Form 4
Ludwig Karin
Senior VP, Clinical Research		2007-05-30 19:56:54106,667
0		106,667Form 3
Patterson Matthew R
Acting CEO & President		2011-04-19 15:53:18106,547
0		106,547Form 4
Lockhart David J
Chief Scientific Officer		2013-06-20 16:10:15100,000
0		100,000Form 4
Gershkowitz Jayne
SVP, Chief Patient Advocate		2015-07-01 17:27:0999,396
0		99,396Form 4
Andrews Kurt J.
SVP, Human Resources		2018-07-05 16:25:3990,469
0		90,469Form 4
RAAB MICHAEL
Director		2024-03-06 17:22:1783,596
0		83,596Form 4
SBLENDORIO GLENN
Director		2024-03-11 17:36:2983,596
0		83,596Form 4
WHEELER CRAIG A
Director		2023-06-12 17:35:0582,844
0		82,844Form 4
Boudes Pol F
Chief Medical Officer		2012-06-06 16:44:0480,000
0		80,000Form 4
Baldry Mark
VP Global Marketing		2015-06-04 18:56:3975,000
0		75,000Form 4
ROBERTS EIRY
Director		2023-06-12 17:38:0274,488
0		74,488Form 4
Prout Samantha
Chief Accounting Officer		2024-04-16 17:42:2073,926
0		73,926Form 4
Valenzano Ken
SVP, Pharmacology & Biology		2015-07-15 17:05:4871,687
0		71,687Form 4
Kelly Michael Aaron
Director		2023-06-12 17:40:1370,681
0		70,681Form 4
ESSNER ROBERT
Director		2021-06-14 19:14:0667,226
0		67,226Form 4
MCGLYNN MARGARET G
Director		2024-03-06 17:21:1266,789
0		66,789Form 4
Peist Kenneth
VP, Legal & IP		2016-01-06 16:18:2563,874
0		63,874Form 4
Simon Mark
Sr. VP, Business Development		2007-05-30 19:52:1963,334
0		63,334Form 3
Bloch Stephen M
Director		2009-02-12 13:31:120
61,700		61,700Form 4
David Allsop
SVP International		2015-04-28 17:01:4350,000
0		50,000Form 4
Kirk John
VP, Regulatory Affairs		2015-06-03 19:18:5845,000
0		45,000Form 4
Schaeffer Orlov S Nicole
SVP, HR & Leadership Devt		2012-02-17 14:38:2845,000
0		45,000Form 4
Branch Douglas A
VP, General Counsel & Sec.		2007-05-30 19:47:2840,002
0		40,002Form 3
Winterbottom Joan
SVP, Human Resources		2013-06-20 16:11:1140,000
0		40,000Form 4
Macaluso Peter M
VP & Corporate Counsel		2013-06-20 16:12:2135,000
0		35,000Form 4
Winkler Robert E
VP, Clin Research & Operations		2012-06-06 16:48:1235,000
0		35,000Form 4
Palling David
Sr VP, Technical Operations		2009-06-30 12:53:5134,040
0		34,040Form 4
Dentzer James E
Chief Financial Officer		2009-10-01 13:49:1332,075
0		32,075Form 4
Licholai Gregory P
VP, Medical Affairs		2009-02-05 12:02:5427,000
0		27,000Form 4
BARER SOL J
Director		2016-06-13 14:37:4420,000
0		20,000Form 4
Shenker Andrew
VP, Clinical Research		2009-02-05 12:16:1018,000
0		18,000Form 4
HAYDEN DONALD J JR
Director		2018-06-11 16:44:5917,807
0		17,807Form 4
John McAdam M
VP, Finance & Accounting		2010-06-17 11:48:3515,000
0		15,000Form 4
Topper James N
Director		2014-06-16 12:50:4515,000
0		15,000Form 4
BARRETT M JAMES
Director
10% Owner		2014-06-16 11:35:1615,000
0		15,000Form 4
Doshi Dipal
SVP Strategy & Bus Dev		2015-07-09 18:26:3514,206
0		14,206Form 4
BARKAS ALEXANDER E
Director		2011-06-14 14:42:2610000
0		10000Form 4
NEFF P SHERRILL
Director		2010-06-17 09:52:5410000
0		10000Form 4
Gilmore Geoffrey
SVP & General Counsel		2012-03-13 13:28:0610000
0		10000Form 4
GLAXOSMITHKLINE PLC
Former 10% Owner (1)		2014-10-28 14:35:360
0		0Form 4
Yu Julie
VP Clinical Ops & Data Mgmt		2015-06-16 20:14:590
0		0Form 4
FHM IV LP
Frazier Healthcare V LP
FHM V LP
FHM V LLC
FRAZIER HEALTHCARE IV LP
FRAZIER AFFILIATES IV LP
10% Owner		2016-03-08 14:35:340
0		0Form 13G
Mount Sinai School of Medicine of New York University
10% Owner		2007-06-07 15:44:370
0		0Form 4